Your browser doesn't support javascript.
loading
Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.
Peraldo-Neia, Caterina; Cavalloni, Giuliana; Fenocchio, Elisabetta; Cagnazzo, Celeste; Gammaitoni, Loretta; Cereda, Stefano; Nasti, Guglielmo; Satolli, Maria Antonietta; Aprile, Giuseppe; Reni, Michele; Avallone, Antonio; Spadi, Rosella; Venesio, Tiziana; Martin, Vittoria; Doglioni, Claudio; Frattini, Milo; Aglietta, Massimo; Leone, Francesco.
Afiliação
  • Peraldo-Neia C; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
  • Cavalloni G; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
  • Fenocchio E; Department of Oncology, University of Turin, IRCCS-Institute of Candiolo, Candiolo, Italy.
  • Cagnazzo C; Clinical Research Office, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
  • Gammaitoni L; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
  • Cereda S; Department of Medical Oncology IRCCS Ospedale San Raffaele, Milan, Italy.
  • Nasti G; Department of Abdominal Oncology, National Cancer Institute "G. Pascale", Naples, Italy.
  • Satolli MA; Medical Oncology Division 1, University Hospital "Città della Salute e della Scienza", Turin, Italy.
  • Aprile G; Department of Oncology, San Bortolo Hospital ULSS8-East District, Vicenza, Italy.
  • Reni M; Department of Medical Oncology IRCCS Ospedale San Raffaele, Milan, Italy.
  • Avallone A; Department of Abdominal Oncology, National Cancer Institute "G. Pascale", Naples, Italy.
  • Spadi R; Medical Oncology Division 1, University Hospital "Città della Salute e della Scienza", Turin, Italy.
  • Venesio T; Pathology Unit, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
  • Martin V; Institute of Pathology, Locarno, Switzerland.
  • Doglioni C; Pathology Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Frattini M; Institute of Pathology, Locarno, Switzerland.
  • Aglietta M; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
  • Leone F; Department of Oncology, University of Turin, IRCCS-Institute of Candiolo, Candiolo, Italy.
PLoS One ; 13(1): e0191593, 2018.
Article em En | MEDLINE | ID: mdl-29352306
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Genes erbB-1 / Receptores ErbB / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Genes erbB-1 / Receptores ErbB / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália